SARS-CoV-2 spike-specific T cellsBiomarker1 paperHumans1LatestNature·30 JunAge-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2Cohort study in peopleImmune responsePaper
Nature·30 JunAge-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2Cohort study in peopleImmune responsePaper